Clinical Efficacy and Safety of Ezetimibe on Major Cardiovascular Endpoints: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Por Battaggia, Alessandro, Donzelli, Alberto, Font, Maria, Molteni, Davide, Galvano, Antonio
Publicado no PLoS One (2015)

Nintedanib in NSCLC: evidence to date and place in therapy

Por Bronte, Giuseppe, Passiglia, Francesco, Galvano, Antonio, Barraco, Nadia, Listì, Angela, Castiglia, Marta, Rizzo, Sergio, Fiorentino, Eugenio, Bazan, Viviana, Russo, Antonio
Publicado no Ther Adv Med Oncol (2016)

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Por Passiglia, Francesco, Bronte, Giuseppe, Bazan, Viviana, Natoli, Clara, Rizzo, Sergio, Galvano, Antonio, Listì, Angela, Cicero, Giuseppe, Rolfo, Christian, Santini, Daniele, Russo, Antonio
Publicado no Oncotarget (2016)

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway

Por Massihnia, Daniela, Galvano, Antonio, Fanale, Daniele, Perez, Alessandro, Castiglia, Marta, Incorvaia, Lorena, Listì, Angela, Rizzo, Sergio, Cicero, Giuseppe, Bazan, Viviana, Castorina, Sergio, Russo, Antonio
Publicado no Oncotarget (2016)

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

Por Bronte, Giuseppe, Silvestris, Nicola, Castiglia, Marta, Galvano, Antonio, Passiglia, Francesco, Sortino, Giovanni, Cicero, Giuseppe, Rolfo, Christian, Peeters, Marc, Bazan, Viviana, Fanale, Daniele, Giordano, Antonio, Russo, Antonio
Publicado no Oncotarget (2015)

Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus

Por Cabibi, Daniela, Caruso, Stefano, Bazan, Viviana, Castiglia, Marta, Bronte, Giuseppe, Ingrao, Sabrina, Fanale, Daniele, Cangemi, Antonina, Calò, Valentina, Listì, Angela, Incorvaia, Lorena, Galvano, Antonio, Pantuso, Gianni, Fiorentino, Eugenio, Castorina, Sergio, Russo, Antonio
Publicado no Oncotarget (2016)